Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

  • John P Neoptolemos
  • Deborah D Stocken
  • Claudio Bassi
  • Paula Ghaneh
  • David Cunningham
  • David Goldstein
  • Robert Padbury
  • Malcolm J Moore
  • Steven Gallinger
  • Christophe Mariette
  • Moritz N Wente
  • Jakob R. Izbicki
  • Helmut Friess
  • Markus M Lerch
  • Christos Dervenis
  • Attila Oláh
  • Giovanni Butturini
  • Ryuichiro Doi
  • Pehr A Lind
  • David Smith
  • Juan W Valle
  • Daniel H Palmer
  • John A Buckels
  • Joyce Thompson
  • Colin J McKay
  • Charlotte L Rawcliffe
  • Markus W Büchler

Abstract

Adjuvant fluorouracil has been shown to be of benefit for patients with resected pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease as well as an effective agent in patients with resected pancreatic cancer.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer10
ISSN0098-7484
StatusVeröffentlicht - 2010
pubmed 20823433